Treatment of vascular disorders of the posterior segment of the eye by topical administration of calcium channel blocking agents
US5431907A · kind A · utility
23Cited by
4References
12Claims
0Family size
Inventors
Key dates
| Filing date | Aug 3, 1994 |
| Grant date | Jul 11, 1995 |
| Priority date | — |
| Expiry date | Aug 3, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/44
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Ischemic disorders of the retina and associated tissues of the posterior segment of the eye are treated by topical administration to the eye of an amount of a calcium channel blocking agent effective to increase blood flow to those tissues. Calcium channel blocking agents of Class I are especially useful, and among these a preferred agent is verapamil hydrochloride.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.